Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
Authors
Keywords
-
Journal
DIABETES
Volume 70, Issue 12, Pages 2903-2916
Publisher
American Diabetes Association
Online
2021-09-27
DOI
10.2337/db21-0385
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Semaglutide attenuates excessive exercise-induced myocardial injury through inhibiting oxidative stress and inflammation in rats
- (2020) Qiang Li et al. LIFE SCIENCES
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cytokine storm intervention in the early stages of COVID-19 pneumonia
- (2020) Xinjuan Sun et al. CYTOKINE & GROWTH FACTOR REVIEWS
- COVID-19 and diabetes: Can DPP4 inhibition play a role?
- (2020) Gianluca Iacobellis DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes is a risk factor for the progression and prognosis of COVID-19
- (2020) Weina Guo et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
- (2020) Wei-jie Guan et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
- (2020) Carmen Ciavarella et al. MOLECULES
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France
- (2020) François Montastruc et al. THERAPIE
- Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
- (2020) Sebastiano Bruno Solerte et al. ACTA DIABETOLOGICA
- Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety
- (2020) Saghir Akhtar et al. JOURNAL OF DRUG TARGETING
- Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?
- (2020) Elena Carboni et al. MEDICAL HYPOTHESES
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
- (2020) Emma Barron et al. Lancet Diabetes & Endocrinology
- Diabetes and Novel Coronavirus Infection: Implications for Treatment
- (2020) David M. Williams et al. Diabetes Therapy
- Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
- (2020) Sebastiano Bruno Solerte et al. DIABETES CARE
- Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
- (2020) Niki Katsiki et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The active GLP-1 analogue liraglutide alleviates H9N2 influenza virus-induced acute lung injury in mice
- (2020) Yu Bai et al. MICROBIAL PATHOGENESIS
- Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis
- (2019) H. Hussein et al. DIABETIC MEDICINE
- Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation
- (2019) María Sánchez-Aguilar et al. PPAR Research
- LIRAGLUTIDE AND SEMAGLUTIDE ATTENUATE INFLAMMATORY CYTOKINES INTERFERON-GAMMA, TUMOR NECROSIS FACTOR-ALPHA, AND INTERLEUKIN-6: POSSIBLE MECHANISM OF DECREASING CARDIOVASCULAR RISK IN DIABETES MELLITUS
- (2019) Stanley Andrew Tan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diabetes drugs and stroke risk: Intensive versus conventional glucose‐lowering strategies, and implications of recent cardiovascular outcome trials
- (2019) Soo Lim et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide 1 in health and disease
- (2018) Andreas Andersen et al. Nature Reviews Endocrinology
- Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
- (2018) Yixing Li et al. Current Cardiology Reports
- Liraglutide Enhances the Activity of the ACE-2/Ang(1–7)/Mas Receptor Pathway in Lungs of Male Pups from Food-Restricted Mothers and Prevents the Reduction of SP-A
- (2018) J. Fandiño et al. International Journal of Endocrinology
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol
- (2018) Humaira Hussein et al. BMJ Open
- Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments
- (2015) Francesco Zaccardi et al. ANNALS OF INTERNAL MEDICINE
- Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart
- (2015) Li-Hui Zhang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
- (2015) Marina Romaní-Pérez et al. ENDOCRINOLOGY
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now